+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Dabigatran Testing"

2022-2026 Global Dabigatran Testing in 90 Countries - Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation - Product Thumbnail Image

2022-2026 Global Dabigatran Testing in 90 Countries - Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

  • Report
  • March 2022
  • Global
From
2020 Dabigatran Test Volume and Sales Forecasts: US, Europe, Japan - Hospitals, Commercial Labs, POC Locations - Product Thumbnail Image

2020 Dabigatran Test Volume and Sales Forecasts: US, Europe, Japan - Hospitals, Commercial Labs, POC Locations

  • Report
  • March 2020
  • Japan, United States, ... Japan, United States, Europe
From
  • 2 Results (Page 1 of 1)
Loading Indicator

The Dabigatran Testing market is a segment of the Diagnostics industry that focuses on the detection of dabigatran, a direct thrombin inhibitor used to prevent stroke and systemic embolism in patients with non-valvular atrial fibrillation. Dabigatran Testing is used to measure the concentration of dabigatran in the blood, which is important for determining the correct dosage and monitoring the effectiveness of the drug. The market is composed of a variety of products, including point-of-care tests, laboratory tests, and home-use tests. Some of the companies in the Dabigatran Testing market include Siemens Healthineers, Abbott, Roche Diagnostics, and Alere. Show Less Read more